COLORECTAL NEOPLASMS
Clinical trials for COLORECTAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL NEOPLASMS trials appear
Sign up with your email to follow new studies for COLORECTAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat colon cancer?
Disease control TerminatedThis study tested a new drug combination (NUFIRI-bev) against the standard treatment (FOLFIRI-bev) for people with advanced colorectal cancer that had spread and could not be removed by surgery. The goal was to see if the new combination was more effective and safer for patients …
Matched conditions: COLORECTAL NEOPLASMS
Phase: PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Two-Pronged attack tested for Tough-to-Treat colon cancer
Disease control TerminatedThis study tested a combination of two drugs, VB-111 and nivolumab, for people with advanced colorectal cancer that had spread to the liver and had stopped responding to standard chemotherapy. The main goals were to check if the treatment was safe and to see if it could cause tum…
Matched conditions: COLORECTAL NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Scientists track immune cells during radiation to boost future cancer treatments
Knowledge-focused TerminatedThis study aimed to understand how high-dose radiation therapy affects the body's immune system in patients with liver, colorectal, skin, or kidney cancers. Researchers collected blood samples from 28 patients before, during, and after radiation treatment to measure immune cell c…
Matched conditions: COLORECTAL NEOPLASMS
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC